3 minutes
University of Edinburgh spin-out Kynos Therapeutics has secured a £9 million investment package led by Epidarex Capital, joined by IP Group and Scottish Enterprise. Kynos has also been awarded £2.5m through an Innovate UK grant to fund a first-time in human Phase 1 clinical trial of its
2 minutes
Edinburgh-based immune-oncology firm Macomics has secured £3.2 million seed funding from Epidarex Capital and the Scottish Investment Bank. Macomics, which is a University of Edinburgh spin-out, will use the proceeds of this fundraising round to develop novel, first-in-class immunotherapies de
3 minutes
International finance firm Epidarex Capital has launched a £102 million venture fund in Edinburgh to build successful life science companies.
SUBSCRIBE
